tiprankstipranks
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Hong Kong Market
1177
Sino Biopharmaceutical
RESEARCH TOOLSreports
Want to see HK:1177 full AI Analyst Report?

Sino Biopharmaceutical (1177) Financial Statements

25 Followers

Sino Biopharmaceutical Financial Overview

Sino Biopharmaceutical's market cap is currently HK$97.03B. The company's EPS TTM is HK$0.2; its P/E ratio is ―; and it has a dividend yield of 1.40%. Sino Biopharmaceutical is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$0.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 31.01B¥ 28.87B¥ 26.20B¥ 26.03B¥ 26.86B
Gross Profit¥ 25.45B¥ 23.53B¥ 21.21B¥ 21.54B¥ 21.53B
Operating Income¥ 6.64B¥ 6.14B¥ 5.79B¥ 5.59B¥ 5.08B
EBITDA¥ 7.79B¥ 6.11B¥ 6.98B¥ 6.69B¥ 19.87B
Net Income¥ 2.28B¥ 3.50B¥ 2.33B¥ 2.54B¥ 14.61B
Balance Sheet
Cash & Short-Term Investments¥ 22.56B¥ 14.60B¥ 14.12B¥ 16.92B¥ 15.79B
Total Assets¥ 76.04B¥ 65.41B¥ 63.60B¥ 64.06B¥ 60.54B
Total Debt¥ 16.08B¥ 9.78B¥ 12.58B¥ 13.98B¥ 12.12B
Net Debt¥ 8.69B¥ 214.26M¥ 3.13B¥ 5.33B¥ 2.52B
Total Liabilities¥ 33.32B¥ 22.63B¥ 25.43B¥ 26.12B¥ 22.81B
Stockholders' Equity¥ 30.68B¥ 31.96B¥ 30.47B¥ 29.75B¥ 30.29B
Cash Flow
Free Cash Flow¥ 7.59B¥ 5.22B¥ 4.36B¥ 4.56B¥ 3.47B
Operating Cash Flow¥ 9.29B¥ 6.62B¥ 6.07B¥ 6.27B¥ 5.37B
Investing Cash Flow¥ -12.41B¥ -1.71B¥ -756.98M¥ -4.07B¥ -2.52B
Financing Cash Flow¥ 4.16B¥ -6.32B¥ -6.55B¥ -3.19B¥ -3.23B
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Income Statement >

Sino Biopharmaceutical Debt to Assets

Balance Sheet >

Sino Biopharmaceutical Cash Flow

Cash Flow >

Sino Biopharmaceutical Forecast EPS vs Actual EPS

Earnings >